Noticias de LLY

Noticias del mercado

Últimas noticias sobre LLY — 1008 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: LLY ✕ 1.008 resultados
06/04/2026 LLY_US — Yahoo Finance
Eli Lilly and Company (LLY) Price Target Raised Following FDA Approval for Fundayo
04/04/2026 LLY_US — Yahoo Finance
Jim Cramer Believes Eli Lilly’s “Weight Loss Pill Will Be a Blockbuster”
03/04/2026 LLY_US — campaignlive.com ES ← EN
Para celebrar su aniversario, Eli Lilly cumple 150 años de todo lo demás
02/04/2026 LLY_US — Yahoo Finance
Is Eli Lilly and Company (LLY) The Best Pharma Stock to Invest In Now?
01/04/2026 LLY_US — investor.lilly.com
FDA approves Lilly's Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions
01/04/2026 LLY_US — PBS
FDA grants speedy approval to Eli Lilly's weight-loss pill for obesity
01/04/2026 LLY_US — Reuters
Lilly's weight-loss pill wins US approval, sets up next battle with rival Novo Nordisk
01/04/2026 LLY_US — CNBC
FDA approves Eli Lilly's GLP-1 pill, opening the next phase of the weight loss drug market
31/03/2026 LLY_US — investor.lilly.com
Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders | Eli Lilly and Company
31/03/2026 LLY_US — PR Newswire
Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
31/03/2026 LLY_US — The New York Times
Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion
30/03/2026 LLY_US — MSN ES ← EN
Jefferies sigue comprando Eli Lilly and Company (LLY)
30/03/2026 LLY_US — Yahoo Finance
Eli Lilly’s (LLY) Shares Up Since Jim Cramer Said He Was a Long Term Believer
30/03/2026 LLY_US — Reuters ES ← EN
Eli Lilly amplía su asociación con Insilico Medicine para el descubrimiento de fármacos impulsado por IA
29/03/2026 LLY_US — Insilico Medicine
Insilico Medicine Announces Global R&D Collaboration with Lilly
29/03/2026 LLY_US — Yahoo Finance
Jefferies Remains a Buy on Eli Lilly and Company (LLY)
28/03/2026 LLY_US — investor.lilly.com
Phase 3b data presented at AAD Annual Meeting show Lilly's Taltz (ixekizumab) plus Zepbound (tirzepatide) delivered superior efficacy for adults with psoriatic arthritis and obesity | Eli Lilly and Company
27/03/2026 LLY_US — investor.lilly.com ES ← EN
EBGLYSS (lebrikizumab-lbkz) de Lilly proporcionó hasta cuatro años de control duradero de la enfermedad en pacientes con dermatitis atópica de moderada a grave | Eli Lilly y compañía
25/03/2026 LLY_US — Healthcare Digital
What is in Eli Lilly & Company’s 2025 Year in Review Report?
25/03/2026 LLY_US — Yahoo Finance
Is Eli Lilly (LLY) The Best Healthcare Stock to Buy According to Jim Cramer?

Página 50 de 51

keyboard_arrow_up